Science Corporation's vision-restoring chip wins EU approval
News Source
β’Wed, 22 Jul 2026 18:18:02 +0000
π° What Happened
Science Corporation won approval from European regulators to sell its PRIMA vision chip. The device helps people who have lost sight due to age-related macular degeneration. Patients get a small chip planted in the back of their eye during an hour-long surgery. They then wear special glasses with cameras that send images to the chip. One patient in France finished reading a 300-page novel using the device. The company also got a special designation from the US FDA that speeds up its review there.
π The Backstory
Science Corporation was founded by Max Hodak, who also co-founded Elon Musk's Neuralink. He left Neuralink in 2021 to start Science Corp. The company wanted to build brain-computer interfaces using a mix of silicon chips and living cells. But first it needed a product that could make money. Age-related macular degeneration affects millions of people worldwide. The disease destroys light-sensitive cells in the eye, making it hard to read or recognize faces. The PRIMA chip is a big step toward giving sight back to people who have lost it.
π― Why It Matters
This technology could change the lives of millions of blind people. If it works well and becomes affordable, it could restore independence to those who have lost their sight.
Science Corporation won approval from European regulators to sell its PRIMA vision chip. The device helps people who have lost sight due to age-related macular degeneration. Patients get a small chip planted in the back of their eye during an hour-long surgery. They then wear special glasses with cameras that send images to the chip. One patient in France finished reading a 300-page novel using the device. The company also got a special designation from the US FDA that speeds up its review there.
Science Corporation was founded by Max Hodak, who also co-founded Elon Musk's Neuralink. He left Neuralink in 2021 to start Science Corp. The company wanted to build brain-computer interfaces using a mix of silicon chips and living cells. But first it needed a product that could make money. Age-related macular degeneration affects millions of people worldwide. The disease destroys light-sensitive cells in the eye, making it hard to read or recognize faces. The PRIMA chip is a big step toward giving sight back to people who have lost it.
This technology could change the lives of millions of blind people. If it works well and becomes affordable, it could restore independence to those who have lost their sight.